Miyake Sarasa, Miyawaki Atsushi, Matsui Hiroki, Kimura Yuya, Yasunaga Hideo
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Pharmacoepidemiol Drug Saf. 2025 May;34(5):e70150. doi: 10.1002/pds.70150.
This study aimed to determine the frequency of discharge prescriptions of drugs that may raise blood pressure (BP) in hospitalized patients with hypertension and identify factors associated with these prescriptions.
A retrospective cross-sectional analysis was conducted using a nationwide inpatient database in Japan, focusing on adults with hypertension discharged from acute care hospitals between April 2021 and March 2022. The primary outcome was the prescription of drugs that may raise BP at discharge. A multivariable linear probability model was employed to assess the relationship between patient and hospital characteristics and the likelihood of receiving these prescriptions.
Among 979 234 patients with hypertension (mean age: 75.3 years, standard deviation: 13.2), 230 792 (23.6%) received at least one drug that may elevate BP at discharge. Non-steroidal anti-inflammatory drugs (NSAIDs) were the most frequently prescribed (46.6%), followed by glucocorticoids (35.3%), atypical antipsychotics (15.1%), antidepressants (7.9%), and Japanese herbal medicines (6.1%). Prescription prevalence was higher among female patients, younger adults, those admitted for medical conditions, non-emergency hospitalizations, patients with disabilities, and those with a Charlson Comorbidity Index of 1. Patients hospitalized for musculoskeletal or skin conditions, transferred to another hospital, or discharged from high-volume hospitals were also more likely to receive these prescriptions.
Drugs that may raise BP are commonly prescribed at discharge for patients with hypertension. This highlights the need for targeted interventions to optimize medication management at discharge, aiming to improve BP control and patient outcomes.
本研究旨在确定可能升高住院高血压患者血压(BP)的出院药物处方频率,并识别与这些处方相关的因素。
利用日本全国住院患者数据库进行回顾性横断面分析,重点关注2021年4月至2022年3月期间从急症医院出院的成年高血压患者。主要结局是出院时开具可能升高血压的药物处方。采用多变量线性概率模型评估患者和医院特征与接受这些处方可能性之间的关系。
在979234例高血压患者(平均年龄:75.3岁,标准差:13.2)中,230792例(23.6%)在出院时至少接受了一种可能升高血压的药物。非甾体抗炎药(NSAIDs)是最常开具的药物(46.6%),其次是糖皮质激素(35.3%)、非典型抗精神病药物(15.1%)、抗抑郁药(7.9%)和中药(6.1%)。女性患者、年轻成年人、因内科疾病入院的患者、非急诊住院患者、残疾患者以及Charlson合并症指数为1的患者的处方患病率较高。因肌肉骨骼或皮肤疾病住院、转至其他医院或从大容量医院出院的患者也更有可能接受这些处方。
可能升高血压的药物在高血压患者出院时经常被开具。这凸显了需要采取有针对性的干预措施,以优化出院时的药物管理,旨在改善血压控制和患者预后。